scholarly journals Long-term outcome of acute tubular necrosis: A contribution to its natural history

2007 ◽  
Vol 71 (7) ◽  
pp. 679-686 ◽  
Author(s):  
F. Liaño ◽  
C. Felipe ◽  
M.-T. Tenorio ◽  
M. Rivera ◽  
V. Abraira ◽  
...  
2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
G. A. Brito ◽  
A. L. Balbi ◽  
J. M. G. Abrão ◽  
D. Ponce

Aims of our study were to describe the long-term survival in patients surviving an acute tubular necrosis (ATN) episode and determine factors associated with late mortality. We performed a prospective cohort study that evaluated the long-term outcome of 212 patients surviving an ATN episode. Mortality at the end of followup was 24.5%, and the probability of these patients being alive 5 years after discharge was 55%. During the followup, 4.7% of patients needed chronic dialysis. Univariate analysis showed that previous CKD (), cardiovascular disease (), age greater than 60 years (), and higher SCr baseline (), after 12 months () and 36 months (), were predictors of long-term mortality. In multivariate analysis, older age (HR = 6.4, CI 95% = 1.2–34.5, ) and higher SCr after 12 months (HR = 2.1, 95% CI 95% = 1.14–4.1, ) were identified as risk factors associated with late mortality. In conclusion, 55% of patients surviving an ATN episode were still alive, and less than 5% required chronic dialysis 60 months later; older age and increased Scr after 12 months were identified as risk factors associated with late death.


2014 ◽  
Vol 113 (3) ◽  
pp. 171-176 ◽  
Author(s):  
Anne Roscher ◽  
Jaina Patel ◽  
Stacy Hewson ◽  
Laura Nagy ◽  
Annette Feigenbaum ◽  
...  

2019 ◽  
Vol 56 ◽  
pp. 85-89
Author(s):  
Ana Herranz Barbero ◽  
Sergi Cesar ◽  
Johanna Martinez-Osorio ◽  
Adriana Margarit ◽  
Julio Moreno ◽  
...  

2016 ◽  
Vol 150 (4) ◽  
pp. S390
Author(s):  
Steven Jeuring ◽  
Dion Wintjens ◽  
Anke Wesselius ◽  
Tim van den Heuvel ◽  
Maurice Zeegers ◽  
...  

2010 ◽  
Vol 42 (10) ◽  
pp. 724-728 ◽  
Author(s):  
Kadakkal R. Radhakrishnan ◽  
Naim Alkhouri ◽  
Sarah Worley ◽  
Susana Arrigain ◽  
Vera Hupertz ◽  
...  

Hepatology ◽  
2014 ◽  
Vol 59 (6) ◽  
pp. 2276-2285 ◽  
Author(s):  
Sith Siramolpiwat ◽  
Susana Seijo ◽  
Rosa Miquel ◽  
Annalisa Berzigotti ◽  
Angeles Garcia-Criado ◽  
...  

2006 ◽  
Vol 244 (1-2) ◽  
pp. 77-87 ◽  
Author(s):  
T.M. Burns ◽  
P.J.B. Dyck ◽  
A.J. Aksamit ◽  
P.J. Dyck

Neurosurgery ◽  
2009 ◽  
Vol 65 (1) ◽  
pp. 7-19 ◽  
Author(s):  
Bradley A. Gross ◽  
H. Hunt Batjer ◽  
Issam A. Awad ◽  
Bernard R. Bendok

ABSTRACT CAVERNOUS MALFORMATIONS OF the basal ganglia and thalamus present a unique therapeutic challenge to the neurosurgeon given their unclear natural history, the risk of surgical treatment, and the unproven efficacy of radiosurgical therapy. Via a PubMed search of the English and French literature, we have systematically reviewed the natural history and surgical and radiosurgical management of these lesions reported through April 2008. Including rates cited for “deep” cavernous malformations, annual bleeding rates for these lesions varied from 2.8% to 4.1% in the natural history studies. Across surgical series providing postoperative or long-term outcome data on 103 patients, we found an 89% resection rate, a 10% risk of long-term surgical morbidity, and a 1.9% risk of surgical mortality. The decrease in hemorrhage risk reported 2 years after radiosurgery might be a result of natural hemorrhage clustering, underscoring the unproven efficacy of this therapeutic modality. Given the compounded risks of radiation-induced injury and post-radiosurgical rebleeding, radiosurgery at modest dosimetry (12–14 Gy marginal doses) is only an option for patients with surgically inaccessible, aggressive lesions.


Sign in / Sign up

Export Citation Format

Share Document